Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...

Gov. Wes Moore made lowering drug costs a key campaign promise, making advocates of the law confident that their greatest ...

In Thursday's meeting, the director of the FDA's Center for Drug Evaluation and Research said plans for coming layoffs were ...

Drs. Jay Bhattacharya and Marty Makary progressed along partisan lines to a full Senate vote on their confirmations for NIH and FDA, respectively.

The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.

It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...

Replacing benzene rings with small-ring bridged hydrocarbons can improve a drug’s physicochemical and pharmacokinetic profile. This protocol describes the synthesis of the potential meta-arene ...

Dr. Marty Makary, a Johns Hopkins surgeon who is poised to become the next commissioner of the Food and Drug Administration, ...

The state’s insurance regulator has demanded detailed information about patients and their medications, raising privacy ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Section 5A RTA 1988 - Driving or being in charge with concentration of specified controlled drug above specified limit The offence at section 5A RTA 1988 is driving, attempting to drive or being in ...

The Food and Drug Administration (FDA ... double-masked phase 3 LYNX-2 trial (ClinicalTrials.gov NCT06349759), which is evaluating the safety and efficacy of phentolamine ophthalmic solution ...